VitaFusions IV review

The claim on the figure is the interesting part. Most sellers who price flat say so in a banner somewhere and leave you to wonder whether it applies to the product you are looking at; this one stamps the words on the price of each program individually, which is the stronger form of the promise and the one a low-dose reader most wants settled. Taken at face value it means the dose is a clinical decision here rather than a budgetary one — which cuts both ways, since a flat price at every dose is exactly the structure that charges a quarter-dose patient the full-dose rate. The refusal that follows is about the unit, not the claim. Neither number carries a period: not a month, not a supply length, not a visit. Without one, the figures cannot be compared against the monthly rates that make up nearly all of this market, and you cannot work out an annual cost from them. The wording on the cheaper program compounds it slightly, since "starting" and "any dose" describe different pricing behaviors and both appear on the same line. What the page does do firmly is close off the fee structure — no membership, no contract, no automatic drafting — which is a short list of exactly the things that most often turn a low headline into a larger bill.

Vs median

Not comparable — no per-month rate is published — the verified string carries no monthly figure

Market

$59–$1300/mo is the full published spread in our ranking

Structure

Same price at every dose

Consult

Included in the price

Dietitian

Not included

Labs

Not required

Pricing

Flat at every dose

Price last updated

August 2026

VitaFusions IV does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.

The claim on the figure is the interesting part. Most sellers who price flat say so in a banner somewhere and leave you to wonder whether it applies to the product you are looking at; this one stamps the words on the price of each program individually, which is the stronger form of the promise and the one a low-dose reader most wants to see settled. Taken at face value it means the dose is a clinical decision here rather than a budgetary one — which cuts both ways, since a flat price at every dose is exactly the structure that charges a quarter-dose patient the full-dose rate. The refusal that follows is about the unit, not the claim. Neither number carries a period: not a month, not a supply length, not a visit. Without one, the figures cannot be compared against the monthly rates that make up nearly all of this market, and a reader cannot work out an annual cost from them. The wording on the cheaper program compounds it slightly, since "starting" and "any dose" describe different pricing behaviors and both appear on the same line. What the page does do firmly is close off the fee structure — no membership, no contract, no automatic drafting — which is a short list of exactly the things that most often turn a low headline into a larger bill.

Neither figure carries a billing period, so no rate can be compared or annualized.

• One program is described as both "starting" and "any dose" on the same line.
• A flat price at every dose means a quarter dose costs what a full one does.

VitaFusions IV is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.

Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.

• What microdosing GLP-1 costs
• Low dose vs full dose
• What a flat price costs at a low dose
• The true annual cost of a plan